Triple-vessel coronary involvement and giant aneurysm in a 6-year-old boy with kawasaki disease: a case report Authors: Mohammad-Taghi Majnoon, Mohammad Mehdi Rajabi, Sahar Hemati, Vahid Ziaee, Mohammad Rafati Navaei, Behdad Gharib Published: 2026 ABSTRACT BackgroundKawasaki disease (KD) is an acute systemic vasculitis of unknown origin. It represents one of the most important causes of acquired heart disease in the pediatric population. Coronary artery involvement is the most serious complication and may result in aneurysm formation and thrombosis. However, simultaneous involvement of all three major coronary arteries and giant aneurysm is rare and usually indicates severe disease.Case presentationThis case report describes a 6-year-old boy with KD who developed progressive involvement of all three major coronary arteries despite standard treatment. The patient received intravenous immunoglobulin (IVIG) on the eighth day of illness, after which the fever resolved. However, follow-up imaging revealed a giant aneurysm of the left anterior descending (LAD) artery along with progressive dilation of the left circumflex (LCX) and right coronary arteries (RCA). During the clinical course, mural thrombosis developed within the LAD aneurysm, and the patient was readmitted for further management. Intensive medical therapy was initiated, including corticosteroids, cyclosporine, infliximab, anticoagulation, and antiplatelet agents. Coronary angiography demonstrated partial patency of the LAD with preserved distal run-off; therefore, surgical intervention was deferred. During follow-up, improvement of the aneurysms in the RCA and LCX was observed, whereas the LAD aneurysm and associated thrombosis persisted. Despite these findings, the patient remained clinically stable with preserved cardiac function and normal daily activities.ConclusionThis case report documented a rare occurrence of triple-vessel coronary involvement with a giant LAD aneurysm and thrombosis in KD. This study highlighted that, despite severe coronary abnormalities and resistance to standard treatment, favorable clinical outcomes may still be achieved with medical therapy and close long-term follow-up. Introduction Kawasaki disease (KD) is an acute systemic vasculitis of unknown cause. KD is one of the most common causes of acquired heart disease in children. It mainly affects children younger than 5 years. In most regions, the annual incidence is about 10–25 per 100,000 children under five years of age [1]. The diagnosis of KD is clinical. Persistent fever for at least five days is the key feature. The principal clinical signs include bilateral non-exudative conjunctivitis, polymorphous rash, changes in the lips and oral mucosa, changes in the extremities, and cervical lymphadenopathy. Classic KD is diagnosed in the presence of fever plus at least four of these five criteria. Incomplete KD should be considered in children with prolonged fever and fewer criteria, particularly when laboratory findings or echocardiography indicate coronary involvement [2, 3]. The main target of the disease is the vascular system. Coronary artery involvement is the most serious and potentially fatal complication. Coronary changes include dilation, aneurysm formation, and thrombosis. If left untreated, about 25% of patients may develop coronary aneurysms. Giant aneurysms and coronary thrombosis are the most dangerous complications. They can lead to myocardial ischemia, infarction, or sudden death [4, 5]. Coronary artery abnormalities usually appear within the first 2–4 weeks after the onset of fever. For early detection, echocardiography should be performed at diagnosis, again at 1–2 weeks, and at 4–6 weeks after disease onset. More frequent follow-up may be needed in high-risk patients [1, 6]. Involvement of all three major coronary arteries in KD is uncommon. In this case report, we present a 6-year-old boy with KD who developed progressive involvement of all three major coronary arteries. He was initially discharged in stable condition after medical treatment. However, she was readmitted due to the development of a giant coronary aneurysm and thrombosis. Case presentation A 6-year-old boy (24 kg) with typical KD was admitted to a hospital in Karaj, Iran, due to coronary involvement. On day 8 of illness, he received Intravenous immunoglobulin (IVIG) (2 g/kg), after which fever resolved. Initial echocardiography showed coronary involvement. He was discharged on a high anti-inflammatory dose of aspirin (80 mg/kg/day divided into four doses, 2 g daily). One week later, repeat echocardiography showed persistent coronary dilation. Coronary computed tomography angiography (CCTA) revealed a large fusiform aneurysm in the mid-proximal LAD (36.7 mm length, 13.4 × 12.8 mm AP diameter, Z-score > 10) without mural thrombosis, as well as ectasia of the LCX (max 5.2 mm, Z-score + 7) and proximal RCA (5.9 mm, Z-score > 10). Due to persistent coronary involvement despite initial treatment, the patient was referred to Children’s Medical Center (CMC). At CMC, the patient was afebrile and in the subacute phase, so he received antiplatelet aspirin (3–5 mg/kg/day, 100 mg daily), warfarin, cyclosporine (50 mg twice daily), prednisolone (5 mg twice daily), and a single dose of infliximab (200 mg). He was discharged after one day. Two weeks later, echocardiography showed no improvement (Z‑scores: LAD/RCA > 10, LCX + 5.5). One week later, repeat echocardiography revealed progression of coronary dilation with development of thrombosis (Fig. 1). He was readmitted with complaint of exertional chest pain. ECG showed no ischemia, and myocardial function was normal. Fig. 1Echocardiography showing aneurysmal LAD (block arrow) with a large, broad-based, non-mobile mural thrombus (red arrow) Echocardiography showing aneurysmal LAD (block arrow) with a large, broad-based, non-mobile mural thrombus (red arrow) After readmission, repeat CT angiography showed diffuse coronary involvement. There was aneurysmal dilation of the proximal and mid LAD (35.5 mm in length, luminal diameter 24 mm) with a large, broad-based, non-mobile mural thrombus causing > 50% obstruction (Fig. 2). The distal LAD remained patent. Focal dilation of the proximal LCX (4.5 mm) and a focal mid RCA aneurysm (7.5 × 13 mm) were noted, while the proximal RCA was not opacified. Heparin infusion (15–22 units/kg/hour), aspirin (100 mg daily), and clopidogrel (24 mg daily) were initiated. Cyclosporine (50 mg twice daily), prednisolone (5 mg twice daily), and an additional infliximab dose were continued. Fig. 2CTA showing aneurysmal LAD (block arrow) with a large, broad-based, non-mobile mural thrombus (red arrow); the yellow arrow indicates the patent origin of the LAD CTA showing aneurysmal LAD (block arrow) with a large, broad-based, non-mobile mural thrombus (red arrow); the yellow arrow indicates the patent origin of the LAD Laboratory tests showed an erythrocyte sedimentation rate (ESR) of 42 mm/h and C-reactive protein (CRP) of 25 mg/L. Due to elevated inflammatory markers, corticosteroid pulse therapy with intravenous methylprednisolone (700 mg daily) was administered for three days, followed by oral prednisolone. After pulse therapy, ESR and CRP returned to normal ranges. Tests for p-ANCA, c-ANCA, and f-ANA were all negative. Despite regression of LCX and RCA dilation after medical treatment, there was no significant improvement in the size of the LAD aneurysm or the extent of thrombosis. A cardiovascular surgeon was consulted regarding possible coronary artery bypass grafting (CABG). Coronary angiography (Fig. 3) demonstrated approximately 50% patency of the LAD lumen, with acceptable vessel size in both proximal and distal segments. Other coronary arteries had normal size and adequate run-off. Based on these findings, the surgical team recommended continuation of medical management. Fig. 3Coronary angiography in multiple planes showing an aneurysm in the mid portion of the LAD (block arrow) with a patent distal segment and adequate run-off; other coronary arteries were patent with normal size Coronary angiography in multiple planes showing an aneurysm in the mid portion of the LAD (block arrow) with a patent distal segment and adequate run-off; other coronary arteries were patent with normal size The patient was discharged on cyclosporine, rosuvastatin, warfarin, aspirin, and clopidogrel. Ten days later, follow-up echocardiography showed improvement in the RCA and LCX aneurysms. However, the LAD aneurysm and associated thrombosis remained largely unchanged (Fig. 4). Currently, the patient attends school and maintains relatively normal daily activities. Fig. 4Echocardiography showing persistent LAD aneurysm with thrombosis (red arrow) Echocardiography showing persistent LAD aneurysm with thrombosis (red arrow) Discussion Coronary artery involvement is the most serious complication of KD. While mild coronary dilation is relatively common, giant aneurysms (≥ 8 mm) are uncommon [4]. A study in Japan reported a prevalence of 0.16% for giant coronary artery aneurysms in KD patients [7]. In most patients, coronary abnormalities involve one or two vessels, most frequently the LAD or RCA [8]. Simultaneous involvement of all three major coronary arteries (LAD, LCX, and RCA) is rare and indicates a severe inflammatory phenotype. In this case, a giant LAD aneurysm (13 mm) developed in association with ectasia of the LCX and RCA, followed by mural thrombosis. This combination indicates severe coronary involvement and a higher risk of ischemic complications. Similar to our patient, a case report in Kuwait described an infant with involvement of all three major coronary arteries who developed thrombosis [9]. IVIG is the standard first-line treatment for KD and is recommended to be initiated within the first 10 days of illness. IVIG significantly reduces the risk of coronary artery aneurysm formation [10]. However, about 10%–20% of patients are resistant to initial IVIG and remain at risk for persistent inflammation and progressive coronary involvement. These patients are considered to have IVIG-resistant disease and are at higher risk for severe coronary complications [11]. In this case, despite timely IVIG on day 8, coronary dilation progressed to a giant aneurysm with thrombosis, indicating refractory disease. Escalation therapy with corticosteroids, cyclosporine, and infliximab was initiated to control inflammation and prevent further coronary damage. Giant coronary aneurysms, especially in the LAD, have a high risk of thrombosis due to high turbulent flow. In this patient, LAD thrombosis developed despite immunomodulatory therapy. Heparin was started, followed by long-term warfarin, aspirin, and clopidogrel, with close monitoring by echocardiography and CT angiography. This approach aligns with current recommendations for high-risk KD patients with giant aneurysms and thrombosis [1, 12]. CABG is reserved for KD patients with critical stenosis, severe ischemia, or hemodynamic compromise. It is a safe and effective intervention for young children with KD. The results of a systematic review and meta-analysis revealed that the mortality rate after CABG in KD patients is 0.28% [13]. Also, existing literature has reported the safety and effectiveness of CABG in infants and young [14, 15]. In this case, surgery was deferred because 50% of the LAD lumen remained patent, proximal and distal segments were adequate, the patient was stable, and ECG showed no ischemia. Medical management with anticoagulation, antiplatelet therapy, and immunomodulation was therefore preferred, with close follow-up. In this patient, despite timely administration of IVIG, immunomodulatory therapy, and anticoagulation, thrombosis persisted within the giant LAD aneurysm. However, the patient maintained preserved cardiac function, showed no evidence of ischemia, and was able to engage in normal daily activities, including attending school. This favorable outcome highlights the potential for vascular remodeling in high-risk KD and underscores the importance of long-term surveillance to detect late complications and guide ongoing management. Conclusion This case report documents the challenging management of a high-risk KD patient with triple-vessel involvement, giant aneurysms, and thrombosis, which did not respond as expected to standard treatments. However, despite the persistent involvement of the LAD, the patient demonstrated preserved cardiac function and had no limitations in daily life activities. This article emphasizes the potential for cardiac and vascular remodeling in severe KD cases, even in the absence of a complete response to treatment. It underscores the importance of careful management and long-term follow-up in such severe cases, which may ultimately lead to favorable outcomes despite initially poor prognostic factors.